Skip to content
Injection Allopathic

Atropine 0.6 mg/ml injection

Generic: Atropine Sulfate (Injection)

Company: Chemist Laboratories Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength0.6 mg/ml
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated March 4, 2025.

Compare

Same generic, same strength

Sorted by price per injection. Ask your pharmacist before you switch brands.

Atropine Sulfate (Injection) 0.6 mg/ml injections

Prices as listed on BestinMeds.

2 brands listed
Atropin, box of 502.52 taka per injection
Atropine, box of 50 (this medicine)5.00 taka per injection

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Atropine Sulfate (Injection) guide

Indications

Atropine Sulfate Injection is indicated in- Cardiovascular disorders: It is used in a variety of disorders or circumstances in which bradyarrhythmias occur. It is frequently used in sudden onset bradyarrhythmias and although it may also be employed for the initial treatment of chronic arrhythmias, cardiac pacing is generally preferred for long-term control. Examples of acute use include the prevention and treatment of arrhythmias associated with anaesthesia, the treatment of other drug-induced arrhythmias, and in cardiac arrest due to asystole. It has been used in the management of bradycardia of acute myocardial infarction; however, caution is required, as it may exacerbate ischaemia or infarction in these patients. Anaesthetic premedication: It is given before the induction of general anaesthesia to diminish the risk of vagal inhibition of the heart and to reduce the salivary and bronchial secretions. Anticholinesterase and mushroom poisoning. For control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block.

Dosage and administration

In cardiovascular disorders: Typical initial doses are in the range of 0.5 to 1.0 mg intravenously. In less severe cases doses may be repeated, as necessary, upto a total dose of 0.03 mg per kg body-weight (about 2 mg); suggested dosage intervals have ranged from 3 to 5 minutes to 1 to 2 hours. In severe instances, as in asystole, a total dose of 0.04 mg per kg (about 3 mg) may be given; some authorities have recommended that the total amount should be given in three divided doses of 1 mg at 3 to 5 minute intervals whereas others consider that 3 mg should be given as a single dose. As anaesthetic premedication: 300 to 600 mcg may be given by subcutaneous (S.C.) or intramuscular (I.M.) injection, usually 30 to 60 minutes before anaesthesia. Alternatively 300 to 600 mcg may be given intravenously immediately before induction of anaesthesia. It may also be given in combination with upto 10 mg morphine sulphate by S.C. or I.M. injection about an hour before anaesthesia. Suitable paediatric premedication doses are: Children weighing upto 3 kg: 100 mcg subcutaneously. Children weighing 7-9 kg: 200 mcg subcutaneously. Children weighing 12-16 kg: 300 mcg subcutaneously. Children weighing 20-27 kg: 400 mcg subcutaneously. Children weighing 32 kg: 500 mcg subcutaneously. Children weighing 41 kg: 600 mcg subcutaneously. In anticholinesterase and mushroom poisoning: It is used in very large doses, e.g. beginning with a dose of 2 mg intravenously or intramuscularly and repeating every 5 to 15 minutes as necessary until signs and symptoms disappear. Doses of up to 100 mg may be needed in the first 24 hours, and lower oral doses should be continued to prevent reappearance of symptoms. For control of muscarinic side-effects of neostigmine: 0.6 to 1.2 mg by intravenous injection in conjunction with neostigmine methylsulphate. Infants and children are particularly susceptible to toxic effects of atropine.

Side effects

Dryness of the mouth with difficulty in swallowing and talking, thirst, reduced bronchial secretions, dilatation of the pupils (mydriasis) with loss of accomodation (cycloplegia) and photophobia, flushing, dryness of skin, transient bradycardia followed by tachycardia with palpitations and arrhythmias, difficulty in micturition, as well as reduction in the tone and motility of GIT leading to constipation. Occasionally vomiting may also occur.

Precautions and warnings

It should be used with caution in children, and in geriatric patients, who may be more susceptible to its adverse effects. It is generally advisable to be cautious in giving atropine to any patient with diarrhoea. Due to the risk of provoking hyperpyrexia atropine should not be given to patients, especially children when the ambient temperature is high. It should also be used cautiously in patients with fever. Persons with Down's syndrome appear to have an increased susceptibility to the actions of atropine. It should be used with caution in conditions characterised by tachycardia such as thyrotoxicosis, heart failure, and in cardiac surgery, where it may further accelerate the heart rate. Care is required in patients with acute myocardial infarction as ischaemia and infarction may be made worse. It should be given with care to patients with hypertension. Atropine may cause mental confusion, especially in the elderly. Reduced bronchial secretion caused by systemic administration of atropine may be associated with the formation of mucous plugs. In the treatment of parkinsonism, increases in dosage and transfer to other forms of treatment should be gradual and antimuscarinic agents should not be withdrawn abruptly. Minor reactions may be controlled by reducing the dose until tolerance has developed.

Pregnancy and lactation

It has negligible effects on the human uterus and is not teratogenic. Small quantities of atropine appears in breast milk when the drug is given to lactating mothers. It has also been reported to impair milk production, although this is not conclusively documented.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250